BEAM
Beam Therapeutics Inc
Price:  
28.90 
USD
Volume:  
1,391,705.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BEAM WACC - Weighted Average Cost of Capital

The WACC of Beam Therapeutics Inc (BEAM) is 8.3%.

The Cost of Equity of Beam Therapeutics Inc (BEAM) is 8.30%.
The Cost of Debt of Beam Therapeutics Inc (BEAM) is 7.25%.

Range Selected
Cost of equity 7.20% - 9.40% 8.30%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.50% 7.25%
WACC 7.2% - 9.4% 8.3%
WACC

BEAM WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.72 0.81
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.20% 9.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0 0
Cost of debt 7.00% 7.50%
After-tax WACC 7.2% 9.4%
Selected WACC 8.3%